-
Symbol
-
EGRX
-
Investment type
-
Equity / Common stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
811K shares
-
Security Ownership
-
6.24%
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP ownership in Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX)
2025-02-19 - NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 811K shares of Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX).
This represents 6.24% percent ownership of the company.